The ubiquitin-proteasome system and signal transduction pathways regulating Epithelial Mesenchymal transition of cancer

71Citations
Citations of this article
81Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Epithelial to Mesenchymal transition (EMT) in cancer, a process permitting cancer cells to become mobile and metastatic, has a signaling hardwire forged from development. Multiple signaling pathways that regulate carcinogenesis enabling characteristics in neoplastic cells such as proliferation, resistance to apoptosis and angiogenesis are also the main players in EMT. These pathways, as almost all cellular processes, are in their turn regulated by ubiquitination and the Ubiquitin-Proteasome System (UPS). Ubiquitination is the covalent link of target proteins with the small protein ubiquitin and serves as a signal to target protein degradation by the proteasome or to other outcomes such as endocytosis, degradation by the lysosome or specification of cellular localization. This paper reviews signal transduction pathways regulating EMT and being regulated by ubiquitination. © 2012 Voutsadakis; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Voutsadakis, I. A. (2012). The ubiquitin-proteasome system and signal transduction pathways regulating Epithelial Mesenchymal transition of cancer. Journal of Biomedical Science. https://doi.org/10.1186/1423-0127-19-67

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free